PENPenumbra, Inc.
Price
+25%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, price roughly fair, growth steady, the market undecided.
We sell our products to healthcare providers primarily through our direct sales organization in the United States, most of Europe, Canada, Australia and Singapore, as well as through distributors in select international markets. We generated revenue of $1,403.7 million, $1,194.6 million and $1,058.5 million for the years ended December 31, 2025, 2024 and 2023, respectively. This represents an annual increase of 17.5% and 12.9%, respectively.
In the company’s own words · 10-K filed Feb 25, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Penumbra, Inc. (PEN) reported revenue of $390M in Q2 2026 (quarter ended Jun 30, 2026), up 15% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $35M (8.9% of revenue). For the full year FY2025, revenue was $1.40B (+17% year on year) and net income $178M. Its largest product in Q2 2026 was Thrombectomy at $259M, 66% of the disclosed total, well ahead of Embolization And Access at 34%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 30, 2026Penumbra, Inc. Reports Second Quarter 2026 Financial Results.Earnings release · press release
- May 6, 2026Penumbra, Inc. Reports First Quarter 2026 Financial Results.Earnings release · press release
- Feb 25, 2026Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $390.0MThe company’s own SEC segment disclosure.
- Thrombectomy$259.0M66%
- Embolization And Access$131.1M34%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.